NCT02379052View on ClinicalTrials.gov

Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)

PHASE2CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

February 17, 2017

Study Completion Date

July 10, 2017

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

Dupilumab

DRUG

Placebo

Trial Locations (14)

Unknown

Idaho Falls

Chicago

Urbana

Indianapolis

Iowa City

Chevy Chase

Boston

New York

Asheville

Chapel Hill

Cincinnati

Philadelphia

Salt Lake City

Fairfax

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY